{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:35:54Z","timestamp":1787510154190,"version":"build-2736575974"},"reference-count":23,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,10,24]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Immunotherapy for treatment of hematological malignancies is immunosuppressive, and chronic immunosuppression is a risk factor for PML. Early diagnosis is vital for instituting prompt immune reconstitution as treatment; brain biopsy is necessary in suspicious cases.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017008201","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T20:25:40Z","timestamp":1508358340000},"page":"2041-2045","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":42,"title":["Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review"],"prefix":"10.1182","volume":"1","author":[{"given":"Elizabeth C.","family":"Neil","sequence":"first","affiliation":[{"name":"Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6290-7818","authenticated-orcid":false,"given":"Lisa M.","family":"DeAngelis","sequence":"additional","affiliation":[{"name":"Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2017,10,18]]},"reference":[{"key":"2019111607115304600_B1","doi-asserted-by":"crossref","first-page":"F1000 Faculty Rev):1424","DOI":"10.12688\/f1000research.7071.1","article-title":"Progressive multifocal leukoencephalopathy","volume":"4","author":"Adang","year":"2015","journal-title":"F1000 Res"},{"issue":"1","key":"2019111607115304600_B2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00415-014-7530-5","article-title":"Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature","volume":"262","author":"Wijburg","year":"2015","journal-title":"J Neurol"},{"issue":"11","key":"2019111607115304600_B3","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/CVI.00489-14","article-title":"Inter- and intralaboratory comparison of JC polyomavirus antibody testing using two different virus-like particle-based assays","volume":"21","author":"Kardas","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"1-2","key":"2019111607115304600_B4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2015.05.003","article-title":"JC virus granule cell neuronopathy: a cause of infectious cerebellar degeneration","volume":"354","author":"Henry","year":"2015","journal-title":"J Neurol Sci"},{"issue":"4","key":"2019111607115304600_B5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","article-title":"Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis","volume":"9","author":"Tan","year":"2010","journal-title":"Lancet Neurol"},{"issue":"16","key":"2019111607115304600_B6","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/cncr.28712","article-title":"Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project","volume":"120","author":"Carson","year":"2014","journal-title":"Cancer"},{"issue":"4","key":"2019111607115304600_B7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.24371","article-title":"Persistence and pathogenesis of the neurotropic polyomavirus JC","volume":"77","author":"Wollebo","year":"2015","journal-title":"Ann Neurol"},{"issue":"6","key":"2019111607115304600_B8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1756285615602832","article-title":"Progressive multifocal leukoencephalopathy: current treatment options and future perspectives","volume":"8","author":"Pavlovic","year":"2015","journal-title":"Ther Adv Neurol Disorder"},{"issue":"5","key":"2019111607115304600_B9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jiph.2014.11.006","article-title":"Progressive multifocal leukoencephalopathy (PML) in a patient with lymphoma treated with rituximab: a case report and literature review","volume":"8","author":"Al-Tawfiq","year":"2015","journal-title":"J Infect Public Health"},{"issue":"4","key":"2019111607115304600_B10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jamaneurol.2013.4668","article-title":"JC polyomavirus granule cell neuronopathy in a patient treated with rituximab","volume":"71","author":"Dang","year":"2014","journal-title":"JAMA Neurol"},{"issue":"7","key":"2019111607115304600_B11","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1136\/annrheumdis-2013-204978","article-title":"A case report of progressive multifocal leucoencephalopathy (PML) associated with adalimumab","volume":"73","author":"Ray","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2019111607115304600_B12","author":"Lane","year":"2015"},{"issue":"3","key":"2019111607115304600_B13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/jnnp-2014-308154","article-title":"Minimal supportive treatment in natalizumab-related PML in a MS patient","volume":"86","author":"Lalive","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"2019111607115304600_B14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1212\/WNL.0000000000000713","article-title":"JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene","volume":"83","author":"Agnihotri","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"2019111607115304600_B15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/JCM.33.2.484-486.1995","article-title":"Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy","volume":"33","author":"Fong","year":"1995","journal-title":"J Clin Microbiol"},{"issue":"5","key":"2019111607115304600_B16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/427698","article-title":"Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy","volume":"40","author":"Bossolasco","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2019111607115304600_B17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1177\/1352458515607651","article-title":"PML risk stratification using anti-JCV antibody index and L-selectin","volume":"22","author":"Schwab","year":"2016","journal-title":"Mult Scler"},{"issue":"5","key":"2019111607115304600_B18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1212\/WNL.0000000000002330","article-title":"Natalizumab-related PML 2 weeks after negative anti-JCV antibody assay","volume":"86","author":"Gagne Brosseau","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"2019111607115304600_B19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1212\/WNL.0000000000002314","article-title":"CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients","volume":"86","author":"Lieberman","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"2019111607115304600_B20","first-page":"117","article-title":"Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group","volume":"87","author":"McGuigan","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"2019111607115304600_B21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2169\/internalmedicine.54.2308","article-title":"Rituximab-associated progressive multifocal leukoencephalopathy derived from non-Hodgkin lymphoma: neuropathological findings and results of mefloquine treatment","volume":"54","author":"Sano","year":"2015","journal-title":"Intern Med"},{"issue":"6","key":"2019111607115304600_B22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s13365-014-0272-4","article-title":"JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection","volume":"21","author":"Maginnis","year":"2015","journal-title":"J Neurovirol"},{"issue":"5","key":"2019111607115304600_B23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/13550280802235916","article-title":"Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells","volume":"14","author":"Chapagain","year":"2008","journal-title":"J Neurovirol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/23\/2041\/878807\/advances008201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/23\/2041\/878807\/advances008201.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T23:30:27Z","timestamp":1603150227000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/23\/2041\/15701\/Progressive-multifocal-leukoencephalopathy-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,18]]},"references-count":23,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2017,10,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017008201","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,18]]}}}